Business, Companies, coronavirus

The NASDAQ-listed Ocugen has rights to commercialise Covaxin in the US.

Bharat Biotech on June 11 said that data from an additional clinical trial will be required now to support the marketing application submission for Covaxin in the US.

The company didn’t clarify the nature of the clinical trial – whether it is a local bridging trial or a Phase -3 trial sought by USFDA.

The company said USFDA didn’t reject its partner Ocugen emergency use authorisation (EUA) but recommended changing the application to a full Biologics License Applications (BLA) approval under changed circumstances.

“The USFDA had earlier communicated that no new EUA’s will be approved for covid vaccines,” Bharat Biotech said in a statement.

“All applications have to follow the biological license application process, which is the standard process for vaccines,” the company said.

The company said the USFDA may have changed its position on EUA, with good herd immunity and a significant percentage of the population vaccinated, the pandemic is reducing in that country.

Ocugen, Bharat Biotech’s partner for Covaxin in the US has said it will no longer seek EUA for its COVID -19 vaccine and will file for full approval of the jab after USFDA asked for additional information and data.

According to Bharat Biotech, Covaxin has received EUA’s 14 countries with more than 50 countries in the process.

“No vaccine manufactured or developed from India has ever received EUA or full licensure from USFDA. When approved, it will be a great leap forward for vaccine innovation and manufacturing from India,” Bharat Biotech said.


Japan travel news, japan travel guides, japan holiday destinations and japan reviews

LATEST NEWS

NEWS RELATED

Udaan invested over Rs 4,000 crore in supply chain, other areas; eyes 100% YoY growth in FY'22

Udaan has invested over Rs 4,000 crore in the past 12-18 months across technology, supply chain, and others areas, and is aiming for 100 per cent year-on-year growth this financial year, according to co-founders of the B2B e-commerce firm. Udaan co-founders Amod Malviya, Sujeet Kumar, and Vaibhav Gupta, in an…

Read more: Udaan invested over Rs 4,000 crore in supply chain, other areas; eyes 100% YoY growth in FY'22

BMW S 1000 R motorcycle launched in India at Rs 17.9 lakh

German luxury automotive group BMW on Tuesday launched the all-new BMW S 1000 R motorcycle model in India with price starting at Rs 17.9 lakh (ex-showroom). The second generation BMW S 1000 R is being imported as a completely built-up unit (CBU) and can be booked at all BMW Motorrad…

Read more: BMW S 1000 R motorcycle launched in India at Rs 17.9 lakh

Toyota Kirloskar Motor resumes production at Bidadi plants

Source: Reuters Toyota Kirloskar Motor (TKM) on Tuesday said it has partially resumed production at its Bidadi-based manufacturing plants in Karnataka. The company noted that it has commenced operations at two facilities with the prescribed workforce strength of 50 percent. The automaker, which sells models like Innova Crysta and Fortuner…

Read more: Toyota Kirloskar Motor resumes production at Bidadi plants

Bharat Biotech defends Covaxin high price in private market, says rate offered by govt 'not sustainable in long run'

The NASDAQ-listed Ocugen has rights to commercialise Covaxin in the US. Bharat Biotech on June 15 defended the pricing of its COVID-19 vaccine Covaxin in the private market. The supply rate of Covaxin to the Government of India at Rs 150 per dose is a “non-competitive price and clearly not sustainable in the long…

Read more: Bharat Biotech defends Covaxin high price in private market, says rate offered by govt 'not sustainable in long run'

Opinion | Like China, India, too, needs its own home-grown e-commerce champions

As questions mount over the business practices of foreign e-commerce giants operating in India, the time has come for us to realise that the country’s online retail sector can never attain its full potential if it becomes the near exclusive preserve of local units of two US-based companies: Amazon and Walmart-owned Flipkart.…

Read more: Opinion | Like China, India, too, needs its own home-grown e-commerce champions

Mazagon Dock to deliver INS Visakhapatnam by Oct, INS Vela by March to Indian Navy

Mazagon Dock Shipbuilders Ltd (MDSL) will deliver the first of the four stealth guided missile destroyers to the Indian Navy by October and a Scorpene-class submarine by the end of the fiscal year. The state-run company under the defence ministry, which has an order book of nearly Rs 50,000 crore,…

Read more: Mazagon Dock to deliver INS Visakhapatnam by Oct, INS Vela by March to Indian Navy

Anupam Rasayan clears debt worth Rs 530 crore from IPO proceeds

Chemicals maker Anupam Rasayan has repaid debt worth Rs 530 crore from the net proceeds of its recently completed initial public offering and will clear an additional Rs 30 crore debt by next quarter ending September, 2021. The company had raised Rs 760 crore through its Initial Public Offering (IPO).…

Read more: Anupam Rasayan clears debt worth Rs 530 crore from IPO proceeds

Semiconductor shortages will hit Q2 volumes also: JLR guidance

Shortage of semiconductors is expected to spill over to Q2 and impact the quarter’s production of Jaguar Land Rover going against the earlier guidance given by it of improvement in the availability of the chips. “The automotive industry has been experiencing a global shortage in the supply of semiconductors, primarily…

Read more: Semiconductor shortages will hit Q2 volumes also: JLR guidance

Electric Vehicles: FAME II scheme for may get 2-year extension till March 2024

How Amazon fares on anti-competitive practices, privacy concerns, workplace conditions

Carlos Ghosn pledges lengthy fight to clear his name

Why Bharat Biotech's Covaxin remains expensive in private markets?

Lupin gets UK nod to launch generic asthma inhaler drug Fostair

Amara Raja to invest in lithium-ion batteries, expand current business verticals

Natco Pharma's marketing partner gets USFDA nod for anti-cancer drug

RattanIndia Power pares Rs 1,219 crore debt in last 15 months

OTHER NEWS